Skip to content
Screener

TransMedics Group, Inc. TMDX Q2 2025 earnings

Reported July 30, 2025 · After market close

Revenue$157.4MBeat by $15.7M
EPS$0.92Beat by $0.44
Revenue estimate$141.6M
EPS estimate$0.48

Next report

Nov 4, 2026 (In 3 weeks)
Revenue estimate$177.5M
EPS estimate$0.30

Financials

Q2 2025

Income statement

See full
Revenue$157.4M+37.7%
Gross profit$96.6M+39.5%
Operating income$36.6M+192%
Net income$34.9M+186%
EPS (diluted)$0.92+163%

Balance sheet

See full
Cash & equivalents$400.6M+10.4%
Total debt$67.5M-0.7%
Total equity$318.1M+67.5%
Total assets$890.5M+17.4%

Cash flow

See full
Operating cash flow$91.6M+256%
CapEx$9.1M-61.8%
Free cash flow$82.5M—

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$4.49B-10.0%
Enterprise value$4.15B-11.5%
P/E62.6×—
P/S8.4×-5.5×

Profitability

See full
Gross margin59.8%-0.9pp
Operating margin14.4%+13.6pp
Net margin13.5%—

Returns & leverage

See full
Return on equity28.2%—
Debt / equity0.2×-0.1×
Current ratio9.9×+0.5×

Segments

By product

See full
Liver Product$116.1M+50.7%
Heart Product$35.7M+13.4%
Lung Product$4.6M-2.5%

By segment

See full
Ocs Transplant Revenue$156.3M+38.2%

FAQ

When did TransMedics Group, Inc. report Q2 2025 earnings?
TransMedics Group, Inc. (TMDX) reported Q2 2025 earnings on July 30, 2025 after market close.
What were TransMedics Group, Inc.'s Q2 2025 revenue and EPS?
TransMedics Group, Inc. reported revenue of $157.4M and eps of $0.92 for Q2 2025.
Did TransMedics Group, Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $141.6M by $15.7M. EPS beat the consensus estimate of $0.48 by $0.44.
How did TransMedics Group, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 37.7% from $114.3M a year earlier and eps grew 162.9% from $0.35.
Where can I find TransMedics Group, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-100228) and the 10-Q periodic report (0000950170-25-100314) directly on SEC EDGAR. The filing index links above go to sec.gov.